In another case, a 32-year-old female with refractory SLE, diagnosed during pregnancy and characterized by serositis, nephritis, cytopenias, hypocomplementemia, and suspected central nervous system involvement, received CD19 CAR-T therapy [26]. The gene discussed is CD19; the disease is systemic lupus erythematosus.